Goto T, Marota J J, Crosby G
Anesthesia Services, Massachusetts General Hospital, Boston 02114.
Anesthesiology. 1994 Feb;80(2):409-16. doi: 10.1097/00000542-199402000-00021.
Noxious stimulation-induced sensitization of the central nervous system has been proposed as a key element in the development of subsequent protracted pain. Accordingly, the authors used the formalin model of pain to test the hypothesis that general anesthesia can produce preemptive analgesia and thereby interfere with noxious stimulation-induced central sensitization.
Rats received 0.9% or 1.8% halothane, 30% or 75% nitrous oxide (N2O), or 75% N2O plus 0.9% halothane (n = 4 or 5 per group). Control rats (n = 5) received only 100% oxygen. Fifteen minutes after the induction of anesthesia, formalin was injected subcutaneously into a hind paw of each rat, and anesthesia was maintained for 5 more min. Because the behavioral pain response to formalin (i.e., flinching of the injected paw) is biphasic, these treatment groups were anesthetized only during phase 1 (acute phase). Another group (n = 5) received 75% N2O only during phase 2 (delayed phase). Reversibility of the N2O effect was tested by the administration of naloxone before phase 1 or naltrexone during phase 2 (n = 5 per group). Finally, additional rats anesthetized as described above (n = 4 or 5 per group) underwent tail-flick testing during anesthesia.
All anesthetics reduced phase 1 pain behavior, but only N2O produced antinociception on tail-flick testing. Thirty percent and 75% N2O, administered during phase 1, suppressed phase 2 flinching 29% and 49%, respectively, whereas nitrous oxide administered after phase 1 did not suppress phase 2 pain behavior. This effect of nitrous oxide was reversed by an opioid antagonist given during phase 1 but not phase 2. Halothane administered during phase 1 had no effect on phase 2 flinching, and it antagonized the effect of 75% N2O.
Nitrous oxide induces dose-dependent preemptive analgesia in this model that is reversed partially by naloxone, thus suggesting the involvement of endogenous opioids in this action. In contrast, halothane has no preemptive analgesic properties and even antagonizes the analgesic effect of nitrous oxide. Hence, the hypnotic potency of an anesthetic is a poor indication of its preemptive analgesic potential.
有害刺激诱导的中枢神经系统致敏被认为是随后持续性疼痛发展的关键因素。因此,作者使用福尔马林疼痛模型来检验全身麻醉可产生超前镇痛并由此干扰有害刺激诱导的中枢致敏这一假说。
大鼠接受0.9%或1.8%的氟烷、30%或75%的氧化亚氮(N₂O),或75% N₂O加0.9%氟烷(每组n = 4或5)。对照大鼠(n = 5)仅接受100%氧气。麻醉诱导15分钟后,将福尔马林皮下注射到每只大鼠的后爪,并再维持麻醉5分钟。由于对福尔马林的行为疼痛反应(即注射爪的退缩)是双相的,这些治疗组仅在第1阶段(急性期)进行麻醉。另一组(n = 5)仅在第2阶段(延迟期)接受75% N₂O。通过在第1阶段前给予纳洛酮或在第2阶段给予纳曲酮来测试N₂O作用的可逆性(每组n = 5)。最后,按上述方法麻醉的额外大鼠(每组n = 4或5)在麻醉期间进行甩尾试验。
所有麻醉剂均减轻了第1阶段的疼痛行为,但只有N₂O在甩尾试验中产生了镇痛作用。在第1阶段给予30%和75%的N₂O分别抑制了第2阶段29%和49%的退缩,而在第l阶段后给予氧化亚氮则未抑制第2阶段的疼痛行为。氧化亚氮的这种作用在第1阶段给予阿片类拮抗剂时被逆转,但在第2阶段未被逆转。在第1阶段给予氟烷对第2阶段的退缩没有影响,并且它拮抗了75% N₂O的作用。
在该模型中,氧化亚氮诱发剂量依赖性超前镇痛,且部分被纳洛酮逆转,这表明内源性阿片类物质参与了这一作用。相比之下,氟烷没有超前镇痛特性,甚至拮抗氧化亚氮的镇痛作用。因此,麻醉剂的催眠效能并不能很好地表明其超前镇痛潜力。